This is stock number 90357A. We are here at Summit Automotive in Fond du Lac, Wisconsin. Your new and used car headquarters. Today we are checking out this super clean 2008 Chevy Impala. This vehicle has the 3.5 liter V6 motor which pumps out 211 horsepower and it has been fully safe and inspected by our service shop per the state of Wisconsin inspection process. Has a fresh oil and filter change all the fluids have been checked and topped off and this car is 100% ready to go. Dark silver metallic is the color we shoot all of our videos in 1080p 60 frames per second so if you have HD capabilities on your computer tablet or smartphone device turn them on right now because it is like you're right here looking at the car with me and definitely your best way to check out the vehicle before seeing it in person. If you want to check out more pictures of this car in the upper right hand part of your screen is a link to our website. Click that and check out all the photos there. Factory alloy rims look at it looks like it has brand new brakes in the front here. Kelley Edge 22560R16 tires with about half the tread left on them. I didn't see any dents or dings in that front fender. Headlight lenses are nice and clear and for being a 2008 it's probably one of the cleanest 2008's you'll find anywhere the hood is in excellent condition I didn't see any dents or dings on that. The passenger side front fenders in nice shape as well and the passenger side front rim is in nice condition too. Down this side of the car you can see just how clean the body is how reflective and mirror like that paint is. We take these HD videos so if you are far away or even if you're close by and just cannot make the trip down you can still see the car hear the car and have confidence in the vehicle that you're looking at before even get here so you can make a smart buying decision from the comfort of your own home. In fact we offer a Summit Auto Fastpass in the upper right hand part of your screen as a link right to our website where you can apply for financing on this car get pre-approved on this car even get a payment quote and if you got a trade you can appraise your trade right on our website so that when you get here the deals all done you're all ready to go looks like those back brakes are brand new as well in that back rim no scuffs or scrapes on that back tires have just as much tread as the front tires coming around to the back of the vehicle you'll notice just how clean that rear bumper is no major dents or dings on it or cracks one tiny little scratch but it has been touched up and not really that big of a deal the trunk is an excellent condition has the deck lid spoiler tail lights are nice and clear we'll check out that trunk here in just a second there no major dents on this rear quarter and for full disclosure this back rim is in excellent shape as well down the rest is side of the car no dents or dings on the doors i'm sorry one tiny little ding on the door there but other than that very very nice you do get power mirrors inside the LT package gives you the black cloth interior there are no rips there are no tears on the seats very nice condition i said we'd take a look at the trunk and we'll definitely do that here so you can see just how much room is back here and how clean it is lots of room back here very very clean and uh if you wanted to know your codes on the car this is where you find them right here feel free to pause the video to check those out and it does come with the spare tire underneath there get the cargo net and very very clean trunk shuts nicely down the rest is side very clean inside the LT package like i said power driver seat no rips or tears on the seat factory floor mats throughout auto headlamps power windows power locks and power mirrors as we hop inside the vehicle here you can see that this one has 52 203 miles instrument cluster is very nice and clean and it does have an outside temperature and compass display and yes it is only 14 degrees here today so not very warm steering wheel is in excellent shape heater works great in this car i can tell you that and it does have AM FM and Sirius XM radio capabilities on this radio dual climate control automatic transmission passenger side floor mat and seat are in excellent condition smells very clean inside this car side curtain airbags and the ceiling is a nice shape has on star capabilities and we'll take a quick look at the back seats and then check out under the hood the back seats are just as nice as the front seats no major rips or tears back here does have the latch child safety system back here i think these seats are fixed back here factory floor mats throughout back there as well and you do get the child safety lock in the back of the doors we'll take a quick look under the hood i would personally like to thank you for checking out the video today and hopefully from this hd video you all been able to tell just how clean this car is all the way around under the hood we have the 3.5 liter v6 motor 211 horsepower engine bay is really clean all the shock towers look great runs really smooth like i said this car has been fully safety and inspected by our service shop has a fresh oil and filter change all the fluids have been checked and topped off the car has been gone through mechanically 100% has brand new brakes all the way around and is 100% ready to go i'd highly recommend it from a quality and condition standpoint considering the age on the vehicle and to see more pictures of this car or one of our other 450 new and used cars trucks scvs minivans wranglers half tons three quarter tons one tons you name it we got it go to our website www.summitauto.com full pictures and descriptions of every single vehicle from two locations all at summit auto.com and if you'd like to check out more hd videos you can go to youtube.com slash summit auto remember to like subscribe and share on this video and all the videos that you see there in fact in a second you will see links to subscribe to our youtube channel on your left a link to more used inventory videos like this one on your right if you have not been to our website on the bottom link to this vehicle on our website click those checks out and we really look forward to helping you with this super clean 2008 Chevy Impala LT thanks again


Yes, hello. Good evening, guys. Can you hear me? Yes. So, okay, I'll wait for a couple of minutes more, only 27 of you are there. Okay, so guys, today we are going to do three chapters. I have prepared the slides for alcohol as well, but these three chapters only it took around 50 slides. So I doubt we'll be able to finish this 4850 slides and more than like more number of sites required for today's session. Okay, if it is there, then we'll add up, right, we'll add the slides into this. But as blog biomolecules polymers definitely will try to finish it today itself, because I was going through the plan the plan that you have now that is the older plan. And according to that plan, we are going to finish the portion on 23rd of Feb, if you see, right? Right. So we have to go a bit fast. I think Feb 7th and or Feb 10th max to max will have the class for this crash course. So that's why we'll try to finish these three chapters today. Okay, I have taken most of the theories in this. Okay, because this need to revise. You know, so theories I have taken properly. Questions are also there. Okay, as block I have taken a few questions of Bunsen classes module. It's a solved questions I did not get the unsolved one so I have taken that so that we can go through the questions also. Okay, so biomolecules polymers and as blog will finish today. Next class also I'll tell you what all chapters will do. Okay. So like half of the things we have done last class only as block. Today we are going to start with sodium here. Okay, so sodium and the compounds of sodium. First one is sodium monoxide. Okay, preparation how it is obtained. I'll just tell you the key points here if you want you can write down in short anyways you're going to get this notes. Okay. So that also from there also you can revise. So first of all, any to is a white amorphous solid. Okay, this property, you should know how it is prepared. It is prepared by heating any to O2 sodium peroxide and O2 O2, or sodium nitrate Na NO3, the sodium peroxide and sodium nitrate you heat with sodium itself. It converts into sodium monoxide and into gas. This reaction is important sodium nitrate on reaction with sodium releases nitrogen gas. Okay. It reacts with water violently forming NaOH right energy releases in this process on heating over 400 degrees Celsius it disproportionates to give peroxide and metallic sodium this reaction is also important. Over 400 disproportionation takes place third one. Okay, with liquid ammonia it forms sodium and sodium hydroxide. Okay, the formation of sodium hydroxide is pretty common in this particular compound that is any to work. Okay, so important point in this, the evolution of end to is important. Okay, and decomposition takes place sodium metal gets involved this is also important to you. Okay, so the next one you see. Sodium hydroxide NaOH sodium hydroxide is commonly called caustic soda we all know, therefore used as a purifier it is prepared by electrolytic process. Okay, there are two electrolytic methods commonly used for the preparation for hydroxide when it's gastro-chelinal cell. Right. In this what happens we have to diaphragm actually what you have to keep in mind in castor channel cathode is made up of mercury reaction is this. Which forms soda amalgam and then this go into the inner compartment if you go through NCRT there that you know explanation is given here. There are two compartments in the outer compartments cathode is made up of mercury where the reduction takes place NaHg forms sodium amalgam and then this go into the inner compartment the anode is made up of graph idea. Where this oxidation takes place. Okay, sodium amalgam removed from the cell, it is then decomposed in a separate cell by water giving NaOH hydrogen and mercury. And mercury is re-circulated so here this anode and cathode thing you must remember what metal we use for this particular things and then cathode. Okay. Next sodium carbonate like it exists in various forms and hydro sodium carbonate is soda ash. Soda ash. Monohydrated form.H2O crystal carbonate heptahydrated 7H2O. It is manufactured by Solvay ammonia soda process name is important. Not for Jay, but in Bitsat need all these exams ask this question okay Solvay or ammonia soda process in this process bring that is a solution of salt. Ammonia and carbon dioxide are the raw materials chemical reactions involves this. Ammonia carbon dioxide and water forms ammonium bicarbonate with react with NaCl forms sodium bicarbonate NH4Cl evolves and on heating the sodium bicarbonate it gives an hydrous form of Na2CO3. Okay. Ammonia Solvay process cannot be used for the production of K2CO3 since KHCO3.


First question, I think it's for everyone, but I'm going to start with Mary. A new tier or access tier called registered access is emerging for genomic data sharing. Can you talk more about why this might be a useful way to manage access to genomic data? So in my presentation, I tried to convey that participant interests are not just in protection and privacy, but also in sharing and maximizing the scientific benefit from participation. So there's a balance. And it does seem too limited to only have, you know, all or nothing, either fully open and unrestricted or controlled access, which often means available only to qualified researchers. You have to have a well-developed protocol that's been approved by an IRB. And so that doesn't seem consistent, for example, with some more exploratory kinds of research or doing reviews preliminary to developing research plans. It doesn't seem to allow bona fide clinicians who might find value in these resources to access them at anything other than that, you know, fully public open level. So registered access, which I think came out of the Global Alliance, seems like a great idea to recognize that there's a gradient of risk and sensitivity and to say, okay, so we're going to find this middle tier, and we're not going to have to require everything that we need, my understanding, with controlled access, but we are going to do more than just, you know, free to everybody in an open or public tier. I guess that the devil is probably in the details in terms of how you would implement it, but probably, I'm looking at Jonathan, he's nodding. There probably are some technologies that can really help with this process. So maybe I'll turn it over to him next. Yeah, that's a great point. I think we wrestled with this a little bit. And I think the one, not quite a caution, but the suggestion I brought there is that we're very clear with what registered access means, because I think it's exactly that, that one organization might implement it technically a bit different than the other. So I think, you know, certainly if NIH was suggesting a certain way of doing it, that would be very helpful and probably lead a lot of other groups to follow in sync. And I think in that case, we would really want to look for, you know, what are the key things that groups commonly check off or don't check off in order to qualify someone for registered access? I think from a technical perspective, those would be the things that we'd want to look for it. It may be a little bit different, but probably defining a subset and agreeing on what they are or are not in certain places is crucial. Oh, Alyssa, did you want to add something? So it would be interesting to hear feedback from the other panelists, but sometimes from the emerging economy perspective, what's lost in the conversation is there need to be on ramps, there needs to be consideration for countries that don't have the same level of infrastructure already set up around data systems. And without that, this very good approach to encourage collaborative use of data starts to become another area where some countries are left behind. So I think there needs to be careful consideration in the standards that are developed and also then how they're employed to make sure that all can be brought along. Yeah, and I guess speaking from the kind of European legal privacy perspective, I've kind of described how, for example, the GDPR seems to export that very high standard, which could be very taxing to be met in certain other contexts. But at a general level, the kind of regulatory framework in Europe, at least, allows for this sort of proportionate approach. And it allows for proportionate data safeguards and levels of privacy protection. The challenge and the challenge for any interaction between Europe and the rest of the world then is working at how that's operationalized according to all of those specific parts of the European law. And that's a lot of work that I'm sure is going on behind the scenes to make that work. So we have, in following up on that, we have our first question in the chat and I'll direct this to Colin. So how should projects citing GDPR be treated for NIH funding and sort of aligned with the NIH GDS policy? Yeah, I mean, for a proper answer to that, you'd need someone very familiar with the NIH policies and someone who's done the work. And I'm not sure if it's been done yet at cross-analyzing the sort of frameworks between that policy and the European legal framework. But I mean, one thing I would know is that we've recently around some other work been looking at some of the NIH policies, for example, in relation to making data available through DBGAP. And what we noted was actually there was, despite the fact that these are totally different legal frameworks, there was a lot of coherence between the terms that are required under those policies and the requirements of the GDPR around, you know, being able to follow up on requests for deletion or removal of data, how you make certain things transparent. So many, many aspects I think are coherent. But for a precise answer, I'm afraid you'd need a good analysis. Yeah, that's a great comment. And then I think also from the NIH's perspective, it's never too early, especially when initiating a new collaboration, to start those discussions with your collaborators early to get a sense of what those barriers are. Or if, like you said, the example with DBGAP, how much already allows for harmonization, whether or not it's in the data access principles or in the consent form, for example. Thank you, Colin. Okay, next question. This is an interesting one. Regarding studies and data resources that include information about minors, what is your perspective on reconcent upon reaching the age of majority? And maybe again, I'll start with Mary. I think that is a tough one because it's currently being debated often. It depends, for example, whether it's even possible. Are you tracking people as they move around so that you can get in touch to do reconcent? But some work I did with a colleague suggested to me that there may be context where it's really important to try to track people so you can enable reconcent. It actually goes back to autism. So there are several large efforts. One's called Missing with the Two Eyes Missing, intended to signal the missing information about autism. But there are parts of the autism community who took that in a very negative light, that their voices were missing, and that this is another one of those efforts that's focused on curing autism or creating tests that would actually prevent people with autism from being born. But so it's a context in which there are people who, when they become adults, consider their condition not a disorder, but an identity. And it seemed to me, I don't know how others feel about this either from work they've done or just kind of at the gut level. But when you can anticipate that that kind of transition might occur, that someone who's enrolled as a minor might develop objections to continued participation. Then you have the strongest case for, again, trying to trap people so that we consent upon age of majority becomes possible. So we have another question. Thank you, Mary, for that. This would be to Jonathan. So given you have some experience now with your Duos pilot, the Duos pilots, do you have any lessons learned that you can share? Have you been able to decrease time for processing the data access request, for example? So, yeah, great question. I think what some people maybe in the community thought was that, you know, there's sort of this idea that the DAC is slow. I think what we learned is that the NIH DACs are actually very fast, especially when compared with the rest of the world of DACs, which tend to be comprised of these other research teams. And I think what we also then realize is that then the efficiency there is at least the current rate of data access requests, not so much on expediting their workflow. They're very, especially at NIH, you know, very defined processes for reviewing DARS. It's actually in structuring the data access requests and helping the researcher give more information more clearly that we found was very important. And then also I would say when you start talking about being able to let a researcher submit a single data access request to multiple DACs, that's something that is very interesting, especially as you go outside of NIH. And again, being able to sign a single agreement like the NIH's data use certification in that library card agreement style, really to help us scale and to help people work together, I think those are some of the biggest wins. And I would just call out again, there's a very DAC focused group at GA4GH that's looking into the next frontier, which is things like, you know, do DACs trust other DACs in their decisions? I think it's a very kind of fascinating question. I think some folks at NCI were bringing this to the table is that they might render a decision, maybe a researcher would be permitted to do any GRU research. Therefore any GRU data set from another DAC may be accessible to them. So ideas like that I think are also on the horizon. Not sure how we'll end up tackling them, but those are some of the things we're taking away. Thanks, Jonathan. Okay. So here's one. It seems as though data privacy is an important topic in general. Do you think more public awareness of large data breaches and scandals such as the Cambridge Analytica Facebook scandal will impact people's willingness to share genomic data for research purposes? And I'll start maybe with Alyssa on that. When you had your conversations with lots of global stakeholders, did you hear any concerns about data privacy? Yeah, certainly. This also, I think brings in the research that Mary was sharing. There is, I think, a great need for the public to be more engaged in understanding both providing their input into data privacy structures that are being developed, as well as understand what it means to have their privacy, to have their data consented, to be used in research both at the academic level or potentially the commercial level. Right now there is a lot of, I think a lot of knowledge of scandals, which are very concerning. There's a lot of mistrust of institutions, both industry institutions and governmental institutions. But to your question about the emerging economy perspective, there are kind of additional layers of mistrust that need to be considered. And this goes back to kind of the idea I mentioned around governance. So, you know, with a significant absence of trust, governance, setting up trustworthy systems becomes really critical and starts to lay the foundation for systems that people can start to believe are going to safeguard their information. So that's a critical step within this process, is not just developing an understanding of what data privacy means, how that data is kept, what's done with it, what your rights are within that, what you're developing trust, but also ensuring that strong systems are in place to enable that data is truly secure and also kept in a way that aligns to the initial concerns. I can just add that in the United States, we have certificates of confidentiality, which were actually strengthened significantly in the 21st Century Cures Act. So they can't prevent hacking or malicious actors doing things without authorization. But they should protect against another kind of concern people have, which is, you know, like the government or law enforcement, getting access to research databases. And some people also mentioned the Golden State Killer case. So I put that up there as potentially spooking people. And it's my understanding that this hasn't been tested in court, but it really should be an effective barrier to that kind of use of genetic information in research databases. Thank you, Mary. I think we have time for one or two quick questions before we close at three. Maybe just one more. So for Jonathan, you had mentioned the data use ontology terms and the project that GA4GH, given that this is a global audience, how easy or hard was it to come to some consensus on a standard set of terms? I don't think it was easy. I think it's taken a number of years and it's an active ontology. So it's actively being developed. We're looking at releasing some updates soon. I think thankfully though, and we'll just invite participation from anyone who's interested in that it's the GA4GH data use and researcher identities work stream, where we constantly groom and refine the ontology, but have a number of representatives from, you know, across all continents, thankfully, who are taking part in contributing. We're even doing a pretty mass effort now to translate the data use ontology into languages other than English. And I think our first one that is finished or near finished is in Japanese. So we're continuing to do that. So definitely a challenge, but thankfully a lot of great collaboration with folks from all around the world at GA4GH. All right. So thank you to all of our viewers who joined us live today. And thank you again to our panelists for your great presentations and for answering all of our questions. Finally, we're grateful to the communications team for all your help with putting this together and streaming it and recording today's session. All right. Thanks again. And I hope you have a great rest of your day. Bye, everyone. Bye now. Thank you.


Welcome to the RemedyForce Venture 18 Early Access Program. I'm Nikhil Deshpande. I'm a Product Manager for RemedyForce. In this video, we will see how RemedyForce Lightning components for self-service can be used in Salesforce communities and for building an app using the Lightning App Builder. This is our legal notice, letting you know that what we are showing you today is regarding a future feature of the product. This information is under NDA and our Safe Harbor Statement applies. Any purchasing decisions should be based on what is generally available today. Lightning components are part of the Salesforce Lightning Component Framework, a modern framework for building single-page applications. Components are reusable units of functionality of an app. For more information on the Lightning Component Framework, refer to Salesforce documentation. In the Venture 18 release of RemedyForce, three Lightning components are being launched. Submit Ticket, Service Requests and Self Help Articles. These components can be found in the list of custom components in Community Builder and in custom Managed Components in Lightning App Builder. The Components Submit Ticket displays a button for submitting a ticket in RemedyForce. The component has two parameters, Overwrite Button Label and Template. Overwrite Button Label allows a custom button label to be displayed. If left blank, the default label Submit A Ticket is displayed. Template allows a specific ticket template to be used for creating the record. Both parameters are optional. The Components Service Requests displays a list of service request forms. The component has three parameters, title, category and number of service requests to display. Title allows a custom title to be displayed in the header. Category filters the list of service requests to just those for the selected category and its subcategories. Number of service requests to display controls the maximum number of service requests forms displayed. All three parameters are optional. The Components Self Help Article displays a list of self help articles. The component has three parameters, title, category and number of articles to display. Title allows a custom title to be displayed in the header. Category filters the list of self help articles to just those for the selected category and its subcategories. Number of articles to display controls the maximum number of self help articles displayed. All three parameters are optional. Remedy Force Lightning Components meld seamlessly with other standard ones from Salesforce or App Exchange. If the service request or self help articles component is added to the main panel, it displays multiple columns of tiles. Whereas if it is added to the sidebar, it displays just one column. If there is a need to have some text instructions displayed along with a submit ticket and component, a Salesforce standard component rich text editor can be added. This flexibility and adaptability of components can be leveraged to provide a superior user experience. The components can be used in Salesforce communities and Lightning App Builder. Let us now look at a demo of the product. I have opened the Community Builder and this is a community already created on a sandbox. You can see that most of the components on this community are standard components. There are a few from Remedy Force. There are different sections of the layout which pre exist on the template used for creating the community. Let us look at the main components here. Here I have added a tabs component. This is a standard Salesforce component that allows us to create tabs. I have created three tabs, IT support, sales and marketing support and facility support. I can add more if necessary. Then I have added the Remedy Force custom components, self help articles and service requests. These components can be found in the list of components under the section header custom components. So I have added both of these components to the IT support tab. I have set up a components self help articles here that displays a maximum of nine records. Next I have a service requests component where I have set up the number of records, maximum records to six. Likewise in the sales and marketing support tab, I have one component for sales and marketing requests and here I have set the category to sales and marketing so that only the relevant service requests will be displayed. Likewise on the facility support tab, I have a service request component. Next I have on the right sidebar, I have added a few rich content editor components to add some text which is basically supporting information for the Remedy Force components. These are the three, the buttons that you see here, all three are the submit ticket components. The reset my password component has a button override label reset my password. If I don't provide any label here then the default submitted ticket label will be displayed. I've also set up the template to password reset so this automatically uses the incident template password reset in the background. Likewise on the setup printer component, I have set up the template to printer setup. There's this submit ticket component where there is a general template or I may choose not to have a template at all. Now let's look at how this community appears to your end users. So this is how it's going to appear. The end users won't know which of these come from Salesforce and which ones from Remedy Force. That's how easily these components, the Remedy Force components blend with the rest of the Salesforce community. So once here on this community, a user can navigate to the appropriate tab and invoke any record, a service request or ticket or knowledge article. Once they click a button, the experience thereafter is similar to Cell Service 3. So you'll see that the service request form that's displayed is identical to that in Cell Service 3.0. If it's a knowledge article, if I open a knowledge article or a self help article, it displays the knowledge article just as it does in Cell Service 3. With just one difference here, because we do not have a maximize window button on this component, we have increased the default width for displaying this component. But the rest of the capabilities on the self help article are identical to Cell Service 3. So you can provide an update, add a text comment and submit. Thank you for watching this overview of Lightning Components for Cell Service. We look forward to hearing your comments on the upcoming Remedy Force Winter 18 release.


Ukrainian guerrillas find out S-400 air defence system coordinates in Moscow. The Ukrainian guerrillas reconnoited the base of the Russian occupiers military unit and discovered the deployment of an air defence unit in the Timiryazovsky district of Moscow. It is the S-400 Triumph air defence system according to the Atezh guerrilla movement. Deployed launchers in the amount of 12 units, radar stations and universal towers for them were found. Presumably these are S-400 Triumph air defence systems, the statement says. According to Atezh, the Russians continue to keep such valuable complexes in the deep rear of Moscow while they are critically lacking at the front. They serve to cover control points of strategic importance, the guerrillas said. At the end of January 2024, the Institute for the Study of War reported that the Russian Federation would re-equip elements of its air defence system in the deep rear due to regular attacks by Ukrainian drones. In some areas there were interruptions in 4G communications. In particular, since last year, Russia has begun to actively strengthen air defence around Moscow and even installed new air defence systems. Assessing the state of Russia's air defence, the defence intelligence of Ukraine said that during the war, Russia had moved air defence systems from the Far East and the northern region to Moscow and temporarily occupied Crimea. In addition, the Russian invaders built a factory in Moscow where they planned to launch the production of air defence missiles.